2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Non-injectable Insulin Market?

The escalation of obesity and diabetes problems are predicted to fuel the expansion of the non-injectable insulin market. Obesity, which is distinguished by an abnormal accumulation of body fat, typically results from an inconsistency between energy intake and expenditure. Diabetes mellitus, frequently termed merely as diabetes, is a collection of metabolic conditions signified by elevated blood sugar levels over an extended duration. Non-injectable insulin is employed to treat diabetes and obesity and may enhance management by overcoming hurdles to insulin treatment, providing possible weight control advantages, and supplying easier treatment options. For example, the World Heart Federation, a Switzerland-based NGO, forecasts that global obesity prevalence is expected to increase by 2022, with about 2.3 billion people, encompassing children and adults, dealing with being overweight and obesity in 2021, a figure projected to jump to 2.7 billion by 2025. Additionally, a report by British Diabetic Association, a UK-based diabetes charity, reported in April 2023 that in the UK, 4.3 million people have diabetes, and over 2.4 million individuals are at a high risk of developing type 2 diabetes. The enrollment numbers for 2021-22 have swelled by 148,951 in comparison to the prior year. Consequently, the escalating issues of obesity and diabetes are propelling the expansion of the non-injectable insulin market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13888&type=smp

What is the Predicted Annual Growth Rate of theNon-injectable Insulin Market Impact Industry Trends by 2034?

The market for non-injectable insulin has seen significant growth in recent years. Projected growth from $1.92 billion in 2024 to $2.16 billion in 2025, with a CAGR of 12.1%, evidences this. Factors contributing to the growth include better patient compliance, an answer to needle phobia, improved quality of life, simpler administration, and steadier blood glucose control.

The market size of non-injectable insulin is predicted to undergo swift expansion in the coming years, climbing to a size of $3.17 billion in 2029, experiencing an annual compounded growth rate of 10.1%. This surge in the anticipated period is due to several factors such as ongoing focus on patient adherence, persistent solutions to needle fear, additional improvements in patient quality of life, continual safety upgrades, and minimized chances of infections and injuries. Key trends during the forecast period are expected to be technological developments, advancement of tech solutions, incorporation of digital health, application of nanotechnology, and combined therapies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13888

What New Market Trends Are Reshaping theNon-injectable Insulin Market and Its Opportunities?

Top firms in the non-injectable insulin market are prioritizing novel advancements in drug delivery systems like the needle-free oral insulin spray. Such advancements aim to boost the quality of life for those managing their diabetes through numerous insulin injections. The needle-free insulin spray offers a painless, needle-free method of managing blood sugar levels, with a handy feature that allows direct spraying into the mouth. For instance, in November 2023, NiedlFree Technologies, an Indian tech platform, launched Ozulin, an oral insulin spray. This product is specifically designed to offer an easier alternative for people with diabetes who may struggle with traditional injectable insulin methods. If approved, Ozulin is poised to revolutionize the world of diabetes management with a more convenient and pain-free substitute to insulin injections.

Who Are the Leading Market Players Fueling Growth in the Non-injectable Insulin Market Trend?

Major companies operating in the non-injectable insulin market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca, Abbott Laboratories, GlaxoSmithKline, Takeda Pharmaceutical, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Ipsen S.A., Cadila Healthcare Limited, Dr. Reddy’s Laboratories Limited, Cipla Limited, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Torrent Pharmaceuticals, Biocon Limited, Wockhardt Limited

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

How is the Global Non-injectable Insulin Market Segemented?

The non-injectable insulin market covered in this report is segmented –

1) By Type: Synthetic Insulin, Semi Synthetic Insulin

2) By Product: Pills, Sprays, Other Products

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Drug Stores

Subsegments:

1) By Synthetic Insulin: Rapid-Acting Synthetic Insulin, Short-Acting Synthetic Insulin, Intermediate-Acting Synthetic Insulin, Long-Acting Synthetic Insulin

2) By Semi-Synthetic Insulin: Modified Insulin Analogs, Combination Insulins, Biosimilar Insulins, Insulin With Extended Release Formulations

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13888&type=smp

Which Geographics are Influencing the Growth of the Non-injectable Insulin Market?

North America was the largest region in the non-injectable insulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-injectable insulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Non-injectable Insulin Market 2025, By The Business Research Company:

Insulin Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Insulin Patch Pumps Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report

Iron Deficiency Injectable Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iron-deficiency-injectable-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: